Eric Venker
President chez ROIVANT SCIENCES LTD.
Fortune : 5 M $ au 30/04/2024
Postes actifs de Eric Venker
Sociétés | Poste | Début | Fin |
---|---|---|---|
IMMUNOVANT, INC. | Directeur/Membre du Conseil | 18/02/2020 | - |
ROIVANT SCIENCES LTD. | Directeur des opérations | 01/11/2018 | - |
President | 01/01/2021 | - | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Directeur des opérations | 01/11/2018 | - |
President | 01/01/2021 | - | |
Corporate Officer/Principal | 01/01/2017 | 01/11/2018 | |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Directeur/Membre du Conseil | - | - |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Directeur/Membre du Conseil | - | - |
Directeur des opérations | - | - | |
Roivant Social Ventures, Inc. | Directeur/Membre du Conseil | 01/01/2014 | - |
Historique de carrière de Eric Venker
Anciens postes connus de Eric Venker
Sociétés | Poste | Début | Fin |
---|---|---|---|
SIO GENE THERAPIES INC. | Directeur/Membre du Conseil | 17/02/2020 | 05/04/2023 |
ARBUTUS BIOPHARMA CORPORATION | Directeur/Membre du Conseil | 01/02/2020 | 25/05/2022 |
Independent Dir/Board Member | 01/02/2020 | 25/05/2022 | |
ROIVANT SCIENCES LTD. | Directeur des opérations | - | - |
President | - | - | |
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Eric Venker
Yale School of Medicine | Doctorate Degree |
St. Louis College of Pharmacy | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Suisse | 2 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 6 |
Chief Operating Officer | 4 |
President | 3 |
Sectorielle
Health Technology | 8 |
Consumer Services | 4 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
IMMUNOVANT, INC. | Health Technology |
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
ROIVANT SCIENCES LTD. | Health Technology |
Entreprise privées | 6 |
---|---|
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Health Technology |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Montes Archimedes Acquisition Corp.
Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA. | Finance |
Roivant Social Ventures, Inc. |
- Bourse
- Insiders
- Eric Venker
- Expérience